Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell-mediated control of HIV-1, HCV, and HTLV-1. (2018)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/sciimmunol.aao2892
PubMed Identifier: 30413420
Publication URI: http://europepmc.org/abstract/MED/30413420
Type: Journal Article/Review
Volume: 3
Parent Publication: Science immunology
Issue: 29
ISSN: 2470-9468